Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches

Pharmacotherapy
Thomas C DowlingGilbert J Burckart

Abstract

To characterize renal function parameters reported in United States Food and Drug Administration-approved prescribing information (package inserts), to compare dosage recommendations for patients with impaired renal function between prescribing information and tertiary drug dosing references, and to evaluate renal function quantification methods most commonly used by clinical pharmacists to develop dosage regimens. Retrospective analysis and Web-based survey. Prescribing information for all new molecular entities (NMEs) approved from 1998-2007 in which dosing recommendations were proposed for patients with impaired renal function, drug monographs from four tertiary drug dosing references (Micromedex, Lexi-Comp, Epocrates Rx, and American Hospital Formulary Service [AHFS] Drug Information) for all identified NMEs, and a Web-based survey of 204 nephrology and critical care pharmacy practitioners. A total of 44 NMEs included renal dosing recommendations in their prescribing information. For all 44 NMEs, prescribing information was reviewed to determine methods to quantify renal function, units of measure reported, and use of chronic kidney disease terminology. The most common index of renal function was creatinine clearance; the C...Continue Reading

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Jun 1, 1988·The American Journal of Medicine·D E Salazar, G B Corcoran
Oct 1, 1973·Annals of Internal Medicine·R W Jelliffe
Mar 1, 1981·Journal of Clinical and Hospital Pharmacy·D Libiszewski
Mar 1, 1997·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·S T McMullinT C Bailey
Apr 19, 2003·Journal of Internal Medicine·J C VerhaveP E de Jong
May 21, 2005·BMJ : British Medical Journal·Liat VidalLeonard Leibovici
Sep 17, 2005·Pharmacotherapy·William R WolowichJuan Carlos Rodriguez
Aug 16, 2006·Annals of Internal Medicine·Andrew S LeveyUNKNOWN Chronic Kidney Disease Epidemiology Collaboration
Sep 9, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Shiraz R GuptaGlen T Schumock
Jan 26, 2007·Journal of Pharmacological Sciences·Ronald A SmuldersTimothy J Hoon
Mar 14, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·William J SpruillHenry H Cobb
Jun 19, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jagbir GillAdeera Levin
Sep 19, 2007·Antimicrobial Agents and Chemotherapy·Xiao-Jian ZhouNathaniel A Brown
Oct 17, 2007·The Medical Journal of Australia·Timothy H MathewUNKNOWN Australasian Creatinine Consensus Working Group
Mar 21, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jasmina A DemirovicManjunath P Pai
May 19, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Lesley A StevensUNKNOWN Chronic Kidney Disease Epidemiology Collaboration
Jul 1, 2009·Kidney International·Daniel E Freedberg

❮ Previous
Next ❯

Citations

Jun 29, 2011·Current Opinion in Nephrology and Hypertension·Joanna Q Hudson, Heather A Nyman
Feb 1, 2012·Antimicrobial Agents and Chemotherapy·Nicolas CharhonSylvain Goutelle
Aug 25, 2012·The Canadian Journal of Hospital Pharmacy·Kimberley L CaouetteNicholas Honcharik
Nov 5, 2015·British Journal of Clinical Pharmacology·Antoine BouquegneauPierre Delanaye
Nov 26, 2015·Néphrologie & thérapeutique·Pierre DelanayeChristophe Mariat
Aug 27, 2015·Diabetes Care·Delphine S TuotUNKNOWN CDC CKD Surveillance Team
Sep 20, 2011·Pharmacotherapy·Sheila M Wilhelm, Pramodini B Kale-Pradhan
Nov 1, 2016·Clinical Trials : Journal of the Society for Clinical Trials·Joshua J GagneNiteesh K Choudhry
Jun 10, 2016·Nephrology·Aarati KhanalRonald L Castelino
Feb 15, 2012·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Wendelin K NelsonThomas J Rutherford
Nov 22, 2013·The Annals of Pharmacotherapy·Daniel L Brown
Nov 22, 2013·The Annals of Pharmacotherapy·John W Ahern, Carl J Possidente
May 24, 2018·British Journal of Clinical Pharmacology·Maria-Eugenia Palacio-LacambraJosé-Bruno Montoro-Ronsano
Aug 16, 2018·British Journal of Clinical Pharmacology·Solène M LavilleUNKNOWN Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Collaborators
May 29, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Hyun Soon SohnHyunah Kim
Sep 17, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jenana Halilovic, Brett H Heintz
May 16, 2020·The Annals of Pharmacotherapy·Sean M McConachieDmitriy M Martirosov
Jun 25, 2020·The Annals of Pharmacotherapy·Sean M McConachieSheila M Wilhelm
Mar 30, 2020·International Journal of Clinical Pharmacy·Sayamon SukkhaJunporn Kongwatcharapong
Feb 6, 2020·BMC Cardiovascular Disorders·Alexandros BriasoulisMary Vaughan-Sarrazin
Oct 13, 2020·Critical Care Medicine·Fréderic SanglaDavid Legouis
Feb 2, 2021·Clinical Pharmacology and Therapeutics·Manjunath P Pai
May 11, 2021·The Annals of Pharmacotherapy·Sean M McConachieSheila M Wilhelm
Jun 2, 2021·Critical Care : the Official Journal of the Critical Care Forum·Matthew E CoveJohn A Kellum

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.